UnitedHealth Group Inc (UNH) : Bennicas Associates reduced its stake in UnitedHealth Group Inc by 1.54% during the most recent quarter end. The investment management company now holds a total of 19,175 shares of UnitedHealth Group Inc which is valued at $2,567,916 after selling 300 shares in UnitedHealth Group Inc , the firm said in a disclosure report filed with the SEC on Oct 17, 2016.UnitedHealth Group Inc makes up approximately 2.43% of Bennicas Associates’s portfolio.
Other Hedge Funds, Including , Cwm reduced its stake in UNH by selling 19,292 shares or 23.46% in the most recent quarter. The Hedge Fund company now holds 62,948 shares of UNH which is valued at $8,429,996. UnitedHealth Group Inc makes up approx 0.60% of Cwm’s portfolio.Premier Asset Managment reduced its stake in UNH by selling 1,050 shares or 1.72% in the most recent quarter. The Hedge Fund company now holds 59,970 shares of UNH which is valued at $8,047,374. UnitedHealth Group Inc makes up approx 2.05% of Premier Asset Managment’s portfolio.Ct Financial Advisors reduced its stake in UNH by selling 1,199 shares or 22.27% in the most recent quarter. The Hedge Fund company now holds 4,186 shares of UNH which is valued at $564,064. UnitedHealth Group Inc makes up approx 0.35% of Ct Financial Advisors’s portfolio.Telemus Capital boosted its stake in UNH in the latest quarter, The investment management firm added 1,683 additional shares and now holds a total of 39,940 shares of UnitedHealth Group Inc which is valued at $5,495,744. UnitedHealth Group Inc makes up approx 0.61% of Telemus Capital’s portfolio.First American Trust Fsb reduced its stake in UNH by selling 8,163 shares or 31.51% in the most recent quarter. The Hedge Fund company now holds 17,747 shares of UNH which is valued at $2,441,987. UnitedHealth Group Inc makes up approx 0.77% of First American Trust Fsb’s portfolio.
UnitedHealth Group Inc closed down -0.27 points or -0.20% at $133.92 with 34,52,918 shares getting traded on Friday. Post opening the session at $134.78, the shares hit an intraday low of $133.89 and an intraday high of $135.51 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
On the company’s financial health, UnitedHealth Group Inc reported $2.17 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Oct 18, 2016. Analyst had a consensus of $2.08. The company had revenue of $46293.00 million for the quarter, compared to analysts expectations of $46061.01 million. The company’s revenue was up 11.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.65 EPS.
Many Wall Street Analysts have commented on UnitedHealth Group Inc. UnitedHealth Group Inc was Upgraded by Argus to ” Buy” on Jul 22, 2016. Company shares were Reiterated by RBC Capital Mkts on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 165 from a previous price target of $157 .
UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.